The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics

BACKGROUND: Erenumab has demonstrated effectiveness for prevention of migraine attacks, but the treatment is costly, and a considerable proportion of patients do not respond to it. The Registry for Migraine study (REFORM) was initiated to discover biomarkers that can predict response to erenumab in...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlsson, William Kristian, Ashina, Håkan, Cullum, Christopher Kjær, Christensen, Rune Häckert, Al-Khazali, Haidar Muhsen, Amin, Faisal Mohammad, Ashina, Messoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257973/
https://www.ncbi.nlm.nih.gov/pubmed/37303034
http://dx.doi.org/10.1186/s10194-023-01604-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257973/
https://www.ncbi.nlm.nih.gov/pubmed/37303034
http://dx.doi.org/10.1186/s10194-023-01604-2

Ejemplares similares